Gln145Met/Leu Changes in Human Immunodeficiency Virus Type 1 Reverse Transcriptase Confer Resistance to Nucleoside and Nonnucleoside Analogs and Impair Virus Replication

Ähnliche Einträge

• Vif is an auxiliary factor of the HIV-1 reverse transcriptase and facilitates abasic site bypass
  von: Cancio, Reynel, et al.
  Veröffentlicht: (2004)
• Effects of Drug Resistance Mutations L100I and V106A on the Binding of Pyrrolobenzoxazepinone Nonnucleoside Inhibitors to the Human Immunodeficiency Virus Type 1 Reverse Transcriptase Catalytic Complex
  von: Locatelli, Giada A., et al.
  Veröffentlicht: (2004)
• Human Immunodeficiency Virus Type 1 Isolates with the Reverse Transcriptase (RT) Mutation Q145M Retain Nucleoside and Nonnucleoside RT Inhibitor Susceptibility
  von: Varghese, Vici, et al.
  Veröffentlicht: (2009)
• High Potency of Indolyl Aryl Sulfone Nonnucleoside Inhibitors towards Drug-Resistant Human Immunodeficiency Virus Type 1 Reverse Transcriptase Mutants Is Due to Selective Targeting of Different Mechanistic Forms of the Enzyme
  von: Cancio, Reynel, et al.
  Veröffentlicht: (2005)
• Drug Resistance Mutations in the Nucleotide Binding Pocket of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Differentially Affect the Phosphorolysis-Dependent Primer Unblocking Activity in the Presence of Stavudine and Zidovudine and Its Inhibition by Efavirenz
  von: Crespan, Emmanuele, et al.
  Veröffentlicht: (2005)